An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States

Active, not recruitingOBSERVATIONAL
Enrollment

140,000

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

August 30, 2025

Study Completion Date

August 30, 2025

Conditions
Acute Respiratory Distress Syndrome (ARDS)Post Intensive Care Syndrome (PICS)
Interventions
OTHER

An ICU admission and a temporally related ARDS diagnosis

"This is a disease study to learn more about the morbidity after an ICU admission and a temporally related ARDS diagnosis.~ARDS stands for acute respiratory distress syndrome."

Trial Locations (1)

07981

Bayer, Whippany

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY

NCT06272942 - An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States | Biotech Hunter | Biotech Hunter